Garry Schwartz, MD
Brooke Army Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Garry Schwartz, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:20 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT00054470 · Tipifarnib Plus Trastuzumab in Treating Patients With Metastatic Breast CancerThe University of Texas Health Science Center at San Antonio · withdrawn · Breast Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:20 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Phase I Clinical Trials of Anti-Cancer AgentsU01CA069853 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Francis J. Giles · fiscal years 1999 to 2007Named on NCT00054470
- Mays Cancer Center at UT San Antonio Health Science CenterP30CA054174 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Robin Jean Leach · fiscal years 1999 to 2026Named on NCT00054470
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.